RAMM Pharma Corp.
RAMM
CNSX
| 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -38.73% | 22.28% | 38.67% | 47.54% | 88.58% |
| Total Depreciation and Amortization | -52.23% | -47.29% | -58.12% | -50.92% | -31.41% |
| Total Amortization of Deferred Charges | -- | -- | -42.86% | -- | -- |
| Total Other Non-Cash Items | 75.32% | -1,680.00% | -44.11% | 95.49% | -733.69% |
| Change in Net Operating Assets | -432.71% | 32.44% | 16.75% | 144.93% | -35.63% |
| Cash from Operations | -106.33% | -35.10% | 86.41% | 79.34% | 56.25% |
| Capital Expenditure | -- | -- | -- | -- | 17,700.00% |
| Sale of Property, Plant, and Equipment | -87.98% | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -88.34% | 2,398.86% | 1,384.76% | 349.66% | 1,957.61% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 64.88% | 70.32% | 80.07% | 70.74% | 16.41% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -101.63% | 2.38% | -- |
| Cash from Financing | 63.64% | 68.85% | 71.65% | 62.35% | 37.55% |
| Foreign Exchange rate Adjustments | 119.25% | -185.85% | -38.89% | -158.33% | -396.83% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -439.48% | 156.98% | 138.89% | 82.62% | 122.06% |